MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Adaptive Biotechnologies Corporation (NASDAQ: ADPT), formerly, Adaptive TCR*
Finance & Acquisitions: Adaptive Biotechnologies
Parents
Adaptive Biotechnologies Corporation (NASDAQ: ADPT), formerly, Adaptive TCR*
Children
*Spun out from the Fred Hutchinson Cancer Research Center with $4.5 million in angel financing (2010)
2011: Adaptive TCR, a Fred Hutch Spinoff, Snags $5.8M to Take Immune System Profiling Up a Notch (2011)
2011: Series B $5.8M by OnBioVC (2011)
2014: Adaptive Corrals $105M to Ramp up Immune System Diagnostics
2019: Sequencing Firm Adaptive's $300M IPO Comes With Pharma Ambitions
2022: Adaptive Biotechnologies (ADPT) Investor presntation - Slideshow_ seekingalpha.com
2022: Adaptive Biotechnologies Corporation 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2024: Adaptive Biotechnologies Corporation 2023 Q4 - Results - Earnings Call Presentation
2025: Genentech Walks Away From $2B Partnership With Adaptive Biotechnologies
Amt: 5.8M Round: Series B (2011)
Digital Biotechnologies Inc.
Jumps
*Key People: Adaptive Biotechnologies
Organization & Developments: Adaptive Biotechnologies